UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001289
Receipt number R000001505
Scientific Title Peripheral blood mononuclear cell implantation for patients with severe ischemic heart disease
Date of disclosure of the study information 2008/08/03
Last modified on 2008/12/01 15:38:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Peripheral blood mononuclear cell implantation for patients with severe ischemic heart disease

Acronym

PROCEED

Scientific Title

Peripheral blood mononuclear cell implantation for patients with severe ischemic heart disease

Scientific Title:Acronym

PROCEED

Region

Japan


Condition

Condition

Severe ischemic heart disease

Classification by specialty

Cardiology Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate safety and efficacy of this treatment.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Safety throughout this treatment.

Key secondary outcomes

Improvement of regional left ventriculer ejection fraction, gloval left ventriculer ejection fraction, perfusion, ischemic mitral regurgitation, symptom.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

CABG+injection of 10^7 autologous peripheral blood mononuclear cells

Interventions/Control_2

CABG+injection of 10^8 autologous peripheral blood mononuclear cells

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patient with severe ischemic heart disease and remained ischemic area after CABG.

Key exclusion criteria

shock
emergency operation
malignant neoplasm
severe retinopathy
severe renal dysfunction(including who receiving chronic hemotherapy)
femail with pregnancy
others

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Issei Komuro

Organization

Graduate School of Medicine,Chiba University

Division name

Department of Cardiovascular Science and Medicine

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan

TEL

043-226-2555

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tohru Minamino

Organization

Graduate School of Medicine,Chiba University

Division name

Department of Cardiovascular Science and Medicine

Zip code


Address


TEL


Homepage URL


Email

t_minamino@yahoo.co.jp


Sponsor or person

Institute

Department of Cardiovascular Science and Medicine,Graduate School of Medicine,Chiba University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health,Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 08 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2008 Year 11 Month 01 Day

Date of IRB


Anticipated trial start date

2008 Year 11 Month 01 Day

Last follow-up date

2011 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2012 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 08 Month 03 Day

Last modified on

2008 Year 12 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001505


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name